Diabetes care devices market seen reaching $130.76 billion by 2030

The Business Research Company says the global diabetes care devices market will grow from $73.91 billion in 2025 to $82.22 billion in 2026, then reach $130.76 billion by 2030. The forecast points to rising diabetes cases, wider use of glucose monitoring and digital management tools, and higher healthcare spending as major growth drivers.

Why it matters: - The diabetes care devices market is expanding as more people need tools to monitor and manage blood glucose. - The forecast suggests demand will keep rising for devices that support daily diabetes management, including monitoring, insulin delivery and connected care. - Faster adoption of digital and real-time glucose technologies could reshape how patients track the condition and how providers manage chronic care.

What happened: - The Business Research Company released a diabetes care devices market report covering market size, trends and global forecasts. - The report pegs the market at $73.91 billion in 2025 and $82.22 billion in 2026. - The report projects the market will reach $130.76 billion by 2030. - The company says the market will grow at an 11.3% CAGR from 2025 to 2026 and a 12.3% CAGR through 2030. - North America held the largest share of the global market in 2025, with Western Europe next.

The details: - The report ties near-term growth to rising diabetes cases worldwide, better access to glucose monitoring devices, growth in outpatient diabetes care services and wider availability of disposable testing supplies. - The longer-term forecast is driven by demand for real-time glucose monitoring, closed-loop insulin delivery systems, digital diabetes management platforms and personalized care tools. - Emerging trends include wider use of continuous glucose monitoring devices, smart insulin delivery systems, mobile health integration, connected diabetes ecosystems and patient-focused monitoring. - The report defines diabetes care devices as tools used to help patients track blood glucose levels and manage the condition more effectively. - The report says regular use of these devices can help reduce risks tied to fluctuating glucose levels and improve quality of life. - Rising healthcare spending is identified as a major driver of market growth. - The report cites CMS data showing US national health expenditure rose 7.5% to $4.9 trillion in 2023, or $14,570 per person, equal to 17.6% of GDP. - CMS also reported hospital spending rose 10.4% to $1,519.7 billion in 2023. - The market report covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa in addition to North America and Western Europe. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics, key technology analysis and future trend analysis. - A free sample is available here. - The full report is available here.

Between the lines: - The growth outlook reflects a broader shift toward connected, data-driven diabetes care rather than standalone test devices. - The emphasis on healthcare spending signals that reimbursement, access and chronic disease budgets may remain key demand drivers. - North America’s lead suggests advanced infrastructure and higher adoption rates still give mature markets an edge, even as emerging regions remain in scope.

What's next: - The market is expected to keep expanding through 2030 as monitoring becomes more continuous and insulin delivery more automated. - Manufacturers and healthcare providers will likely focus on connected systems, mobile tools and personalized care models. - Further growth will depend on adoption of digital platforms, investment in chronic disease management and access to testing and monitoring supplies.

The bottom line: - Diabetes care devices are moving from basic monitoring toward integrated management systems, and the market forecast points to sustained double-digit growth through the decade.